Nardelli-Haefliger D - Search Results

1

Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.

Benmerzoug S, Chevalier MF, Verardo M, Nguyen S, Cesson V, Schneider AK, Dartiguenave F, Rodrigues-Dias SC, Lucca I, Jichlinski P, Roth B, Nardelli-Haefliger D, Derré L. Benmerzoug S, et al. Among authors: nardelli haefliger d. Eur Urol Focus. 2022 May;8(3):748-751. doi: 10.1016/j.euf.2021.06.001. Epub 2021 Jun 17. Eur Urol Focus. 2022. PMID: 34147404 Free article.

2

A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.

Decrausaz L, Gonçalves AR, Domingos-Pereira S, Pythoud C, Stehle JC, Schiller J, Jichlinski P, Nardelli-Haefliger D. Decrausaz L, et al. Int J Cancer. 2011 May 1;128(9):2105-13. doi: 10.1002/ijc.25561. Int J Cancer. 2011. PMID: 20635385 Free article.

3

Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

Decrausaz L, Domingos-Pereira S, Duc M, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D. Decrausaz L, et al. Int J Cancer. 2011 Aug 1;129(3):762-72. doi: 10.1002/ijc.25973. Int J Cancer. 2011. PMID: 21384340 Free PMC article.

4

A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.

Longet S, Schiller JT, Bobst M, Jichlinski P, Nardelli-Haefliger D. Longet S, et al. J Virol. 2011 Dec;85(24):13253-9. doi: 10.1128/JVI.06093-11. Epub 2011 Oct 5. J Virol. 2011. PMID: 21976653 Free PMC article.

5

What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?

Nardelli-Haefliger D, Romero P, Jichlinski P. Nardelli-Haefliger D, et al. Oncoimmunology. 2012 Mar 1;1(2):242-243. doi: 10.4161/onci.1.2.18204. Oncoimmunology. 2012. PMID: 22720257 Free PMC article.

6

Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.

Pieraerts C, Martin V, Jichlinski P, Nardelli-Haefliger D, Derre L. Pieraerts C, et al. Oncoimmunology. 2012 Aug 1;1(5):694-698. doi: 10.4161/onci.20526. Oncoimmunology. 2012. PMID: 22934261 Free PMC article.

7

Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.

Domingos-Pereira S, Decrausaz L, Derré L, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D. Domingos-Pereira S, et al. Mucosal Immunol. 2013 Mar;6(2):393-404. doi: 10.1038/mi.2012.83. Epub 2012 Sep 12. Mucosal Immunol. 2013. PMID: 22968420 Free PMC article.

8

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8⁺ T cells.

Decrausaz L, Pythoud C, Domingos-Pereira S, Derré L, Jichlinski P, Nardelli-Haefliger D. Decrausaz L, et al. Oncoimmunology. 2013 Jan 1;2(1):e22944. doi: 10.4161/onci.22944. Oncoimmunology. 2013. PMID: 23483225 Free PMC article.

9

Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.

Domingos-Pereira S, Derré L, Warpelin-Decrausaz L, Haefliger JA, Romero P, Jichlinski P, Nardelli-Haefliger D. Domingos-Pereira S, et al. J Urol. 2014 Mar;191(3):814-22. doi: 10.1016/j.juro.2013.08.009. Epub 2013 Aug 13. J Urol. 2014. PMID: 23954582 Free article.

10

Immunotherapeutic strategies for bladder cancer.

Chevalier MF, Nardelli-Haefliger D, Domingos-Pereira S, Jichlinski P, Derré L. Chevalier MF, et al. Hum Vaccin Immunother. 2014;10(4):977-81. doi: 10.4161/hv.27621. Epub 2014 Jan 2. Hum Vaccin Immunother. 2014. PMID: 24384699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page